Literature DB >> 18358834

Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry.

Nicolas Ansermot1, Marc Fathi, Jean-Luc Veuthey, Jules Desmeules, Serge Rudaz, Denis Hochstrasser.   

Abstract

OBJECTIVES: The aim of this work was to develop a selective method for the simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood. DESIGN AND METHODS: An automated on-line solid-phase extraction system coupled with liquid chromatography-mass spectrometry (LC-MS) was used. After a simple protein precipitation, the supernatant was load on a C8 column with a mobile phase composed of MeOH/H(2)O (5/95 v/v), supplemented with formic acid 0.02% and sodium formate 1 muM. After column-switching, the analytes were transferred in the back-flush mode on a C18 column with MeOH/H(2)O (65/35). The valve was then commuted to its initial position and the chromatographic separation was performed with a gradient of MeOH/H(2)O (65/35-95/5). The sodium adducts [M+Na](+) were monitored for quantification with an electrospray ionization-single quadrupole MS.
RESULTS: The LC-MS assay was fully validated on a concentration range of 2.5-30 ng/mL for tacrolimus, sirolimus and everolimus and of 50-1500 ng/mL for cyclosporine, allowing a quantification of cyclosporine 2 h post-dose without sample dilution. Trueness, repeatability and intermediate precision were found to be satisfactory.
CONCLUSION: This method provided a selective, rapid and automated procedure that can be easily used for routine quantification of immunosuppressive drugs in most clinical laboratories.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358834     DOI: 10.1016/j.clinbiochem.2008.02.014

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats.

Authors:  N Deblon; L Bourgoin; C Veyrat-Durebex; M Peyrou; M Vinciguerra; A Caillon; C Maeder; M Fournier; X Montet; F Rohner-Jeanrenaud; M Foti
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS.

Authors:  Mustafa Karapirli; Murat Kizilgun; Ozgur Yesilyurt; Husamettin Gul; Zeki Ilker Kunak; Emin Ozgur Akgul; Enis Macit; Tuncer Cayci; Yasemin Gulcan Kurt; Ibrahim Aydin; Hakan Yaren; Melik Seyrek; Erdinc Cakir; Halil Yaman
Journal:  ScientificWorldJournal       Date:  2012-05-02

3.  Effects of Storage Temperature and Time on Stability of Serum Tacrolimus and Cyclosporine A Levels in Whole Blood by LC-MS/MS.

Authors:  İbrahim Kaplan; Hatice Yüksel; Osman Evliyaoğlu; M Kemal Basarali; Gülten Toprak; Leyla Çolpan; Velat Şen
Journal:  Int J Anal Chem       Date:  2015-04-09       Impact factor: 1.885

4.  Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin A and tacrolimus levels in whole blood.

Authors:  Yong-Wha Lee
Journal:  Exp Ther Med       Date:  2013-10-04       Impact factor: 2.447

5.  A reversed phase high performance liquid chromatographic method for determination of rapamycin.

Authors:  Hamideh Sobhani; Alireza Shafaati; Nastaran Nafissi-Varcheh; Reza Aboofazeli
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  Development and validation of a HPLC method for the determination of cyclosporine a in new bioadhesive nanoparticles for oral administration.

Authors:  M Pecchio; H Salman; J M Irache; M J Renedo; M C Dios-Viéitez
Journal:  Indian J Pharm Sci       Date:  2014-03       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.